vs
Lantheus Holdings, Inc.(LNTH)とTyler Technologies(TYL)の財務データ比較。上の社名をクリックして会社を切り替えられます
Tyler Technologiesの直近四半期売上が大きい($575.2M vs $406.8M、Lantheus Holdings, Inc.の約1.4倍)。Lantheus Holdings, Inc.の純利益率が高く(13.3% vs 11.4%、差は1.9%)。Tyler Technologiesの前年同期比売上増加率が高い(6.3% vs 4.0%)。Tyler Technologiesの直近四半期フリーキャッシュフローが多い($239.6M vs $81.4M)。過去8四半期でTyler Technologiesの売上複合成長率が高い(6.0% vs 4.9%)
ランティウス・ホールディングスはグローバルな医療企業で、革新的な診断用造影剤や関連ソリューションの開発・製造・販売を事業の核としています。製品は腫瘍学、循環器学、泌尿器学などの分野に対応し、北米を中心に世界の主要市場で事業を展開しています。
Tyler Technologies, Inc.はアメリカ合衆国テキサス州プラーノに本社を置くテクノロジー企業で、米国公共部門向けに独自開発の専用ソフトウェアを提供している。現在米国内17州とカナダ・オンタリオ州トロントにオフィスを展開している。
LNTH vs TYL — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $406.8M | $575.2M |
| 純利益 | $54.1M | $65.5M |
| 粗利率 | 59.2% | 45.5% |
| 営業利益率 | 19.0% | 13.0% |
| 純利益率 | 13.3% | 11.4% |
| 売上前年比 | 4.0% | 6.3% |
| 純利益前年比 | 558.8% | 0.5% |
| EPS(希薄化後) | $0.86 | $1.50 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $406.8M | $575.2M | ||
| Q3 25 | $384.0M | $595.9M | ||
| Q2 25 | $378.0M | $596.1M | ||
| Q1 25 | $372.8M | $565.2M | ||
| Q4 24 | $391.1M | $541.1M | ||
| Q3 24 | $378.7M | $543.3M | ||
| Q2 24 | $394.1M | $541.0M | ||
| Q1 24 | $370.0M | $512.4M |
| Q4 25 | $54.1M | $65.5M | ||
| Q3 25 | $27.8M | $84.4M | ||
| Q2 25 | $78.8M | $84.6M | ||
| Q1 25 | $72.9M | $81.1M | ||
| Q4 24 | $-11.8M | $65.2M | ||
| Q3 24 | $131.1M | $75.9M | ||
| Q2 24 | $62.1M | $67.7M | ||
| Q1 24 | $131.1M | $54.2M |
| Q4 25 | 59.2% | 45.5% | ||
| Q3 25 | 57.9% | 47.2% | ||
| Q2 25 | 63.8% | 45.8% | ||
| Q1 25 | 63.8% | 47.3% | ||
| Q4 24 | 63.5% | 43.8% | ||
| Q3 24 | 63.9% | 43.7% | ||
| Q2 24 | 64.9% | 44.0% | ||
| Q1 24 | 65.4% | 43.7% |
| Q4 25 | 19.0% | 13.0% | ||
| Q3 25 | 11.4% | 16.4% | ||
| Q2 25 | 23.3% | 16.0% | ||
| Q1 25 | 27.4% | 15.8% | ||
| Q4 24 | 29.1% | 13.2% | ||
| Q3 24 | 35.3% | 15.2% | ||
| Q2 24 | 26.1% | 14.4% | ||
| Q1 24 | 28.8% | 13.1% |
| Q4 25 | 13.3% | 11.4% | ||
| Q3 25 | 7.2% | 14.2% | ||
| Q2 25 | 20.8% | 14.2% | ||
| Q1 25 | 19.6% | 14.3% | ||
| Q4 24 | -3.0% | 12.1% | ||
| Q3 24 | 34.6% | 14.0% | ||
| Q2 24 | 15.8% | 12.5% | ||
| Q1 24 | 35.4% | 10.6% |
| Q4 25 | $0.86 | $1.50 | ||
| Q3 25 | $0.41 | $1.93 | ||
| Q2 25 | $1.12 | $1.93 | ||
| Q1 25 | $1.02 | $1.84 | ||
| Q4 24 | $-0.18 | $1.48 | ||
| Q3 24 | $1.79 | $1.74 | ||
| Q2 24 | $0.88 | $1.57 | ||
| Q1 24 | $1.87 | $1.26 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $359.1M | $1.1B |
| 総負債低いほど良い | $568.7M | $599.7M |
| 株主資本純資産 | $1.1B | $3.7B |
| 総資産 | $2.2B | $5.6B |
| 負債/資本比率低いほどレバレッジが低い | 0.52× | 0.16× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $359.1M | $1.1B | ||
| Q3 25 | $382.0M | $950.8M | ||
| Q2 25 | $695.6M | $892.3M | ||
| Q1 25 | $938.5M | $807.4M | ||
| Q4 24 | $912.8M | $768.0M | ||
| Q3 24 | $866.4M | $544.3M | ||
| Q2 24 | $757.0M | $258.0M | ||
| Q1 24 | $718.3M | $196.9M |
| Q4 25 | $568.7M | $599.7M | ||
| Q3 25 | $567.9M | $599.2M | ||
| Q2 25 | $566.8M | $598.8M | ||
| Q1 25 | $566.1M | $598.4M | ||
| Q4 24 | $565.3M | $597.9M | ||
| Q3 24 | $613.0K | $597.5M | ||
| Q2 24 | $563.2M | $597.1M | ||
| Q1 24 | $562.5M | $596.6M |
| Q4 25 | $1.1B | $3.7B | ||
| Q3 25 | $1.1B | $3.6B | ||
| Q2 25 | $1.2B | $3.6B | ||
| Q1 25 | $1.2B | $3.5B | ||
| Q4 24 | $1.1B | $3.4B | ||
| Q3 24 | $1.2B | $3.3B | ||
| Q2 24 | $1.0B | $3.1B | ||
| Q1 24 | $945.5M | $3.0B |
| Q4 25 | $2.2B | $5.6B | ||
| Q3 25 | $2.3B | $5.5B | ||
| Q2 25 | $2.1B | $5.4B | ||
| Q1 25 | $2.1B | $5.2B | ||
| Q4 24 | $2.0B | $5.2B | ||
| Q3 24 | $2.0B | $5.0B | ||
| Q2 24 | $1.9B | $4.8B | ||
| Q1 24 | $1.8B | $4.6B |
| Q4 25 | 0.52× | 0.16× | ||
| Q3 25 | 0.51× | 0.17× | ||
| Q2 25 | 0.49× | 0.16× | ||
| Q1 25 | 0.49× | 0.17× | ||
| Q4 24 | 0.52× | 0.18× | ||
| Q3 24 | 0.00× | 0.18× | ||
| Q2 24 | 0.55× | 0.19× | ||
| Q1 24 | 0.59× | 0.20× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $90.2M | $243.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $81.4M | $239.6M |
| FCFマージンFCF / 売上 | 20.0% | 41.7% |
| 設備投資強度設備投資 / 売上 | 2.2% | 0.8% |
| キャッシュ転換率営業CF / 純利益 | 1.67× | 3.72× |
| 直近12ヶ月FCF直近4四半期 | $354.1M | $637.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $90.2M | $243.9M | ||
| Q3 25 | $105.3M | $255.2M | ||
| Q2 25 | $87.1M | $98.3M | ||
| Q1 25 | $107.6M | $56.2M | ||
| Q4 24 | $157.7M | $224.8M | ||
| Q3 24 | $175.1M | $263.7M | ||
| Q2 24 | $84.7M | $64.3M | ||
| Q1 24 | $127.2M | $71.8M |
| Q4 25 | $81.4M | $239.6M | ||
| Q3 25 | $94.7M | $251.3M | ||
| Q2 25 | $79.1M | $92.8M | ||
| Q1 25 | $98.8M | $53.8M | ||
| Q4 24 | $141.4M | $221.0M | ||
| Q3 24 | $159.3M | $260.8M | ||
| Q2 24 | $73.5M | $57.7M | ||
| Q1 24 | $119.0M | $64.6M |
| Q4 25 | 20.0% | 41.7% | ||
| Q3 25 | 24.7% | 42.2% | ||
| Q2 25 | 20.9% | 15.6% | ||
| Q1 25 | 26.5% | 9.5% | ||
| Q4 24 | 36.1% | 40.8% | ||
| Q3 24 | 42.0% | 48.0% | ||
| Q2 24 | 18.7% | 10.7% | ||
| Q1 24 | 32.2% | 12.6% |
| Q4 25 | 2.2% | 0.8% | ||
| Q3 25 | 2.8% | 0.7% | ||
| Q2 25 | 2.1% | 0.9% | ||
| Q1 25 | 2.3% | 0.4% | ||
| Q4 24 | 4.2% | 0.7% | ||
| Q3 24 | 4.2% | 0.5% | ||
| Q2 24 | 2.8% | 1.2% | ||
| Q1 24 | 2.2% | 1.4% |
| Q4 25 | 1.67× | 3.72× | ||
| Q3 25 | 3.79× | 3.02× | ||
| Q2 25 | 1.11× | 1.16× | ||
| Q1 25 | 1.47× | 0.69× | ||
| Q4 24 | — | 3.45× | ||
| Q3 24 | 1.34× | 3.47× | ||
| Q2 24 | 1.36× | 0.95× | ||
| Q1 24 | 0.97× | 1.33× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
TYL
| Saas Arrangements | $186.1M | 32% |
| Platform Technologies Segment | $143.3M | 25% |
| Maintenance | $109.4M | 19% |
| Professional Services | $55.3M | 10% |
| Nonrecurring Revenue | $51.3M | 9% |
| Other | $21.4M | 4% |
| Hardware And Other | $8.4M | 1% |